Tweenvest Stocks

Lipigon Pharmaceuticals AB (publ) (DB: 9RP)

Health Care · Biotechnology · SE

€—

— today · — 1Y

Lipigon Pharmaceuticals AB (publ) (DB: 9RP) operates in the Biotechnology industry within the Health Care sector.

trading between 0.00 and 0.02.

Tweenvest scores Lipigon Pharmaceuticals AB (publ) across four factors: quality 35/100. Its strongest factor is quality.

9RP price history

Not enough price history to draw a chart yet.

Key figures

Market cap
—
Revenue (TTM)
—
P/E
—
EPS
-0.08
Dividend yield
—
Beta (5Y)
—
52-week high
€0.02
52-week low
€0.00
Avg volume (3M)
—
Shares outstanding
—
Employees
6
Next earnings
—

About Lipigon Pharmaceuticals AB (publ)

Lipigon Pharmaceuticals AB (publ) develops drugs for lipid related diseases in Sweden. The company's product pipeline consists of Lipisense project for the treatment of severe hypertriglyceridemia disease and familial chylomicronemia syndrome; a gene therapy project for the lipodystrophy, a rare disease of altered fat distribution in the body; therapeutics for dyslipidemia, a general lipid disorder; and RNA drug project for acute respiratory distress syndrome. Lipigon Pharmaceuticals AB (publ) has a collaboration agreement with HitGen Inc. for the development of small molecules for the treatment of dyslipidemia, cardiovascular disease, and other metabolic diseases. The company was founded in 2010 and is based in Umeå, Sweden.

ISIN
SE0015382072
Founded
2010
Listed since
Mar 1, 2021
Exchange
Deutsche Boerse AG
Currency
EUR
CompanyMarket capPriceDay
PhaseRx, Inc.OTCPK: PZRX.Q$12.00$——
ContraFect CorporationOTCPK: CFRX.Q$11.00$0.00—
Notable Labs, Ltd.OTCPK: NTBL.Q$10.00$——
OncoSec Medical IncorporatedOTCPK: ONCS.Q$6.00$0.00—
Calithera Biosciences, Inc.OTCPK: CALA$5.00$0.00-99.00%
Biocept, Inc.OTCPK: BIOC.Q$3.00$0.00-99.50%
Yield10 Bioscience, Inc.OTCPK: YTEN.Q$1.00$——
LadRx CorporationOTCPK: LADX$0.00$0.00-99.50%

Browse every Biotechnology company →

Figures last refreshed Oct 18, 2026.